U.S. patent number D903,109 [Application Number 35/505,321] was granted by the patent office on 2020-11-24 for auto injector.
This patent grant is currently assigned to F. Hoffmann-La Roche AG. The grantee listed for this patent is F. HOFFMANN-LA ROCHE AG. Invention is credited to Florian Wildenhahn.
![](/patent/grant/D0903109/USD0903109-20201124-D00000.png)
![](/patent/grant/D0903109/USD0903109-20201124-D00001.png)
![](/patent/grant/D0903109/USD0903109-20201124-D00002.png)
![](/patent/grant/D0903109/USD0903109-20201124-D00003.png)
![](/patent/grant/D0903109/USD0903109-20201124-D00004.png)
![](/patent/grant/D0903109/USD0903109-20201124-D00005.png)
![](/patent/grant/D0903109/USD0903109-20201124-D00006.png)
![](/patent/grant/D0903109/USD0903109-20201124-D00007.png)
United States Patent |
D903,109 |
Wildenhahn |
November 24, 2020 |
Auto injector
Claims
CLAIM The ornamental design for an auto injector, as shown and
described.
Inventors: |
Wildenhahn; Florian
(Rheinfelden, DE) |
Applicant: |
Name |
City |
State |
Country |
Type |
F. HOFFMANN-LA ROCHE AG |
Basel |
N/A |
CH |
|
|
Assignee: |
F. Hoffmann-La Roche AG (Basel,
CH)
|
Appl.
No.: |
35/505,321 |
Filed: |
October 5, 2017 |
International Registration
Int'l Reg. No. |
Int'l Reg. Date |
Int'l Reg.
Publication Date |
Hague Int'l
Filing Date |
DM/101938 |
Oct 5, 2017 |
Jul 20, 2018 |
Oct 5, 2017 |
Foreign Application Priority Data
Current U.S.
Class: |
D24/113 |
Current International
Class: |
2402 |
Field of
Search: |
;D24/133,137,138,127,112,108,144,146,147 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: Bennett-Hattan; Eliza Z
Attorney, Agent or Firm: IP Attorneys Group, LLC
Description
Fig. 1.1 is a translucent front view of an auto injector in
accordance with my new design;
Fig. 1.2 is another front view thereof;
Fig. 1.3 is a bottom view thereof;
Fig. 1.4 is a side view thereof;
Fig. 1.5 is a top view thereof;
Fig. 1.6 is a bottom perspective view thereof; and
Fig. 1.7 is a top perspective view thereof.
The dashed lines show the medication and mechanism for injection of
the medication seen through the transparent or translucent main
body and form no part of the claim.
* * * * *